VETA-K1® Injection is a yellow, sterile, aqueous colloidal solution of Vitamin K1, with a pH of 5.0 to 7.0, available for injection by intravenous, intramuscular, and subcutaneous routes.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Veta-K1® Injection is indicated in coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.
Veta-K1® Injection is indicated in cattle, calves, horses, swine, sheep, goats, dogs, and cats to counter hypoprothrombinemia induced by ingestion of anticoagulant rodenticides.
Veta-K1® Injection is also indicated to counter hypoprothrombinemia caused by consumption of bishydroxycoumarin found in spoiled and moldy sweet clover.
Veta-K1® Injection contains Phytonadione for the treatment of acute hypoprothrombinemia (with hemorrhage) in cats, dogs, cattle, calves, horses, swine, sheep and goats.
Solution possesses the same type and degree of activity as naturally occurring vitamin K.
- Start-up Therapy
Veta-K1® Injections are used to begin treatment in a critical care situation or hospitalization. (Follow injection therapy with Veta-K1® oral capsules.)
- Stimulation of Prothrombin
Vitamin K stimulates the production via the liver of active prothrombin from a precursor protein.
Drug-induced hypoprothrombinemia responds to interference with vitamin K metabolism.
Phytonadione will not counteract other therapy such as anticoagulant action of heparin.
- Severe reactions, including fatalities, have occurred during and immediately after intravenous injection of phytonadione. IV route should be restricted to those situations where other routes are not feasible and the serious risk involved is considered justified.
- Temporary resistance to prothrombin-depressing anticoagulants may result, especially when larger doses of phytonadione are used.
- Repeated large doses of vitamin K are not warranted in liver disease if the response to initial use of the vitamin is unsatisfactory.
- Pain, swelling and tenderness at the injection site may occur.
- IM injection may result in hematomas.
|List No.||Pack Size||Case Size|